Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.
Significant progress has been made in preventing acute allograft rejection following solid organ transplantation resulting in improved allograft survival. However, long term function still remains disappointing primarily due to chronic allograft rejection. Alloimmune responses primarily defined by the development of antibodies (Abs) to donor mismatched major histocompatibility antigens during the post-transplantation period have been strongly correlated to the development of chronic rejection. In addition, recent studies have demonstrated an important role for autoimmunity including the development of Abs to organ specific self-antigens in the pathogenesis of chronic allograft rejection. Based on this, a new paradigm has evolved indicating a possible cross-talk between the alloimmune responses and autoimmunity leading to chronic rejection. In this review, we will discuss the emerging concept for the role of cellular and humoral immune responses to self-antigens in the immunopathogenesis of chronic allograft rejection which has the potential to develop new strategies for the prevention and/or treatment of chronic rejection.
Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, United States.
Nayan J
NJ
Sarma
Venkataswarup
V
Tiriveedhi
Nataraju
N
Angaswamy
T
T
Mohanakumar
D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D016377:Organ Transplantation; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D058504:Th17 Cells / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D001323:Autoantibodies; D001324:Autoantigens